Serum indoxyl sulfate as an early marker for detecting chronic cyclosporine nephrotoxicity

Pediatrics International

Volumn 52, Issue 2, 2010, Pages 257-261

  Umino, Daisuke ^a   Ohtomo, Yoshiyuki ^b   Hara, Satoshi ^a,c   Someya, Tomonosuke ^a   Fujinaga, Shuichiro ^c   Shimizu, Toshiaki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^c SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

Creatinine; Cyclosporine nephropathy; Cystatin C; Indoxyl sulfate; Renal function; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; CAPTOPRIL; CREATININE; CYCLOSPORIN A; CYSTATIN C; INDICAN; LOSARTAN POTASSIUM; PREDNISOLONE; TELMISARTAN; BIOLOGICAL MARKER; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; ATROPHY; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SAFETY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION TEST; KIDNEY TUBULE DISORDER; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; BLOOD; CHEMICALLY INDUCED; KIDNEY DISEASE; PRESCHOOL CHILD; TOXICITY; YOUNG ADULT;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOSPORINE; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDICAN; KIDNEY DISEASES; MALE; YOUNG ADULT;

EID: 77950195998     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02961.x     Document Type: Article

References (15)

1. Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978 13 : 159 165.
2. Clark AG, Barratt TM. Steroid-responsive nephritic syndrome. In : Barratt TM, Avner ED, Harmon WE (eds). Pediatric Nephrology, 4th edn. Lippincott Williams & Wilkins, Baltimore, 1999 731 747.
3. Durkan AM, Hodson EM, Willis NS, Craig JC. Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials. Kidney Int. 2001 59 : 1919 1927.
4. Hulton SA, Dillion MJ, Barratt TM. Long term cyclosporin therapy in minimal change nephrotic syndrome of childhood. Pediatr. Nephrol. 1994 8 : 401 403.
5. Iijima K, Hamahira K, Tanaka R et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int. 2002 61 : 1801 1805.
6. Niaudet P, Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J. Am. Soc. Nephrol. 1994 5 : 1049 1056.
7. Rosner MH, Bolton WK. Renal function testing. Am. J. Kidney Dis. 2006 47 : 174 183.
8. Jovanovic D, Krstivojevic P, Obradovic I, Durdevic V, Dukanovic L. Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren. Fail. 2003 25 : 123 133.
9. Niwa T, Takeda N, Tatematsu A, Maeda K. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin. Chem. 1988 34 : 2264 2267.
10. Huber AR, Risch L. Recent developments in the evaluation of glomerular filtration rate: Is there a place for beta-trace? Clin. Chem. 2005 51 : 1329 1330.
11. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med. 1994 124 : 96 104.
12. Sakai T, Maruyama T, Imamura H, Shimada H, Otagiri M. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. J. Pharmacol. Exp. Ther. 1996 278 : 786 792.
13. Boumendil-Podevin EF, Podevin RA, Richet G. Uricosuric agents in uremic sera. Identification of indoxyl sulfate and hippuric acid. J. Clin. Invest. 1975 55 : 1142 1152.
14. Ohtomo Y, Fujinaga S, Takada M et al. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity. Pediatr. Nephrol. 2005 20 : 1744 1749.
15. Fujinaga S, Ohtomo Y, Umino D et al. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr. Nephrol. 2007 22 : 71 6.